Promising research? "The SolveCFS BioBank™ was approved by the Genetic Alliance for operation in April 2010, launching with a partnership with GlaxoSmithKline (GSK) and several of the top ME/CFS expert clinicians in the U.S. Current research being conducted on the SolveCFS BioBank™ asks specific questions like,
•Are there autoantibody differences in ME/CFS patients compared to healthy controls?
•Are there immune profile differences in ME/CFS patients compared to healthy controls?
•Are there antibodies to viruses in ME/CFS patients that are different than health controls?
•Are there blood biomarkers that distinguish ME/CFS patients compared to healthy controls?
•Are there epigenetic differences in ME/CFS patients compared to controls?
Between now and the end of 2014, the Solve ME/CFS Initiative will post several blogs that will describe the exciting research coming from the SolveCFS BioBank™." solvecfs-biobank
No comments:
Post a Comment